GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hana Pharm Co Ltd (XKRX:293480) » Definitions » Net Interest Income

Hana Pharm Co (XKRX:293480) Net Interest Income : ₩245 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Hana Pharm Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Hana Pharm Co's net interest income for the three months ended in Mar. 2025 was ₩47 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ₩245 Mil.

Hana Pharm Co Net Interest Income Historical Data

The historical data trend for Hana Pharm Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hana Pharm Co Net Interest Income Chart

Hana Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only 1,062.88 630.18 -315.63 274.89 264.22

Hana Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.15 74.02 65.33 58.73 47.03

Hana Pharm Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩245 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hana Pharm Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of Hana Pharm Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Hana Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hana Pharm Co Ltd (XKRX:293480) » Definitions » Net Interest Income
Comparable Companies
XKRX:102460 XKRX:096760 XKRX:092040 XKRX:001630 XKRX:005500 XKRX:293780 XKRX:271980 XKRX:016580 XKRX:007570 XKRX:234080 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
218 Teheran-ro, 15 Floor, 16 Floor, Narae Building, Gangnam-gu, Seoul, KOR
Website
http://www.hanaph.co.kr
Hana Pharm Co Ltd is a Korea based company engaged in drug development. It offers products for anesthetics, narcotic analgesics, antiemetics, antibiotics, dermatology, urinology, osteoporosis, and central nervous system.

Hana Pharm Co Headlines

No Headlines